Finance
ETF
Cap-Weighted

iShares NASDAQ Biotechnology ETF

$111.42
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.76 (-1.56%) Today
-$1.76 (-1.56%) Today

Why Robinhood?

You can buy or sell IBB and other stocks, options, ETFs, and crypto commission-free!

About

IBB tracks the performance of a market-cap-weighted index of biotechnology and pharmaceutical companies listed on the NASDAQ.

Market Cap
8.54B
Price-Earnings Ratio
-207.74
Dividend Yield
0.48
Average Volume
2.29M
High Today
$111.53
Low Today
$109.77
Open Price
$109.88
Volume
710.56K
52 Week High
$122.97
52 Week Low
$89.01

Collections

Finance
ETF
Cap-Weighted
Health
Biotechnology
Pharmaceutical

News

Seeking AlphaMar 19

Biotech Hype Is Worth Every Penny, But IBB Is Not The Best Way To Play It

IBB is not a bad way to gain some exposure to biotech stocks, but is not the best way to do so. Healthcare industry is poised to grow for many years to come, and biotech stocks are considered hot by many investors and analysts. Executive summary Technological advancements have taken the world by storm, and these technological developments are changing some industries for good. For example, the retail shopping industry has been disrupted by the rise of e-commerce, and the cable-TV industry has been trumpe...

98
CNBCMar 4

Biotech stocks are tracking for their best quarter ever — here's how to play it

Biotech stocks took a tumble Monday with the XBI S&P biotech ETF and IBB Nasdaq biotech ETF each falling by more than 1 percent. Even so, the two ETFs remain sharply higher for the year. The equal-weighted XBI ETF has rallied 26 percent in 2019, tracking for its best quarter ever, while the market-cap weighted IBB ETF has gained 18 percent. David Nadig, managing director of ETF.com, said if an investor wants exposure to biotech, one of those ETFs stands above the other. "If you're playing biotech, you're...

259
CNBCMar 4

Biotech stocks are going wild, and these two could be your best bet for a bigger breakout

Investors can trust this kind of biotech rally, says pro 2:54 PM ET Fri, 1 March 2019 | 03:06 Biotech is blazing higher. The IBB biotechnology ETF is on track for its best quarter in six years, adding 19 percent in a rally twice as steep as the gains on the XLV health care ETF. Craig Johnson, chief market technician at Piper Jaffray, says biotech should continue to be a healthy trade. "For a lot of investors, they're trying to play catch-up at this point in time, and they're going to continue to play th...

136
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.